574例不可手术肺癌患者放化疗后生活质量恢复情况
该前瞻性队列研究评估了574例接受分次(≥40 Gy)放化疗的不可手术肺癌患者的生活质量,在基线、放疗结束时及放疗后3个月至5年随访。放疗结束后症状评分中位数从基线8(IQR 4-14)升至17(IQR 4-25)(P < 0.0004),3至24个月恢复至中位数13但仍显著高于基线(P < 0.0004),与基线无临床相关差异。结论为放疗后症状暂时增加,生活质量恢复至基线水平并稳定至5年。
要点
- 放疗结束时生活质量量表评分中位数由基线8(IQR 4-14)升至17(IQR 4-25)(P < 0.0004)。
- 随访3至24个月量表评分恢复至中位数13,仍显著高于基线(P < 0.0004),但无临床相关差异。
- 合并肺部疾病和WHO评分≥2的患者通常报告更多不适。
核心结论
- 患者完成放化疗后不适暂时增加,生活质量恢复至基线水平并在5年随访内保持稳定。
研究设计与样本
- 前瞻性队列研究,纳入574例接受分次(≥40 Gy)放化疗的不可手术肺癌患者,评估基线、放疗结束时、放疗后3个月、6个月、1年及此后每年至5年的生活质量。
主要发现
- 574例分析患者随访期间问卷依从率为87%至97%。
- 生活质量量表评分中位数从基线8(IQR 4-14)升至放疗结束后的17(IQR 4-25)(P < 0.0004),表明不适增加。
- 随访3至24个月量表评分恢复至中位数13,但仍显著高于基线(P < 0.0004)。
- 与基线相比未观察到临床相关差异。
- 合并肺部疾病和WHO评分≥2的患者通常报告更多不适。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Quality of life (QoL) of patients with inoperable lung cancer can be negatively affected by both the disease and its treatment, generally consisting of (chemo)radiotherapy. The aim of this study was to prospectively assess QoL in patients with inoperable lung cancer, treated with (chemo)radiotherapy and to assess whether patient- and/or treatment-related characteristics were associated with poorer QoL. METHODS: This prospective cohort study evaluated QoL and patient-, tumor-, and treatment characteristics from inoperable lung cancer patients, treated with fractionated (≥40 Gy) (chemo)radiotherapy. Patients were evaluated at baseline, upon finishing radiotherapy, and 3 months, 6 months, 1 year, and yearly thereafter up to 5 years after radiotherapy. The QoL assessment consisted of questionnaires evaluating lung cancer-specific and treatment-related complaints using scale scores. RESULTS: Compliance rates of the 574 analyzed patients ranged from 87 to 97 % during follow-up. Complaints increased after radiotherapy, as the QoL scale scores increased from median 8 (interquartile range, IQR 4-14) to 17 (IQR 4-25) after completing radiotherapy (P < 0.0004), indicating more complaints. From 3 months to 24 months of follow-up, scale scores returned to a median of 13, but were significantly higher compared to baseline (P < 0.0004). However, no clinically relevant differences compared to baseline were observed. Patients with pulmonary comorbidity and WHO scores ≥ 2 generally reported more complaints. CONCLUSION: Patients experienced a temporary increase in complaints after finishing (chemo)radiotherapy, QoL returned to baseline level and remained stable up to five years of follow-up.
引用
- Nies M, Wijsman R, Chouvalova O, et al. Recovery of quality of life in 574 patients with inoperable lung cancer undergoing (chemo)radiotherapy. Clin Transl Radiat Oncol. 2025. PMID: 40093741. doi:10.1016/j.ctro.2025.100935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。